Showing 4,341 - 4,360 results of 42,065 for search '"China"', query time: 0.11s Refine Results
  1. 4341
  2. 4342
  3. 4343
  4. 4344
  5. 4345
  6. 4346
  7. 4347

    Clinicopathological relationship between PM2.5 exposure and acute exacerbations of chronic obstructive pulmonary disease by Anfeng Cui, Yingying Shao, Yang Wang, Haodong Wang, Jiayi Song, Caiji Liu, Ningning Shen, Zhiqing Yang, Wangliang Zhang, Tiane Luo, Chen Wang

    Published 2025-02-01
    “…This data was paired with Shanxi's average monthly PM2.5 data from the Tracking Air Pollution in China (TAP) dataset. Correlations between PM2.5 levels and AECOPD clinicopathological features were assessed using ANOVA and Spearman’s correlation. …”
    Get full text
    Article
  8. 4348
  9. 4349
  10. 4350

    Land subsidence and rebound response to groundwater recovery in the Beijing Plain: A new hydrological perspective by Dexin Meng, Beibei Chen, Huili Gong, Shubo Zhang, Rui Ma, Chaofan Zhou, Kunchao Lei, Lewei Xu, Xincheng Wang

    Published 2025-02-01
    “…Study region: Beijing Plain (BJP), China. Study focus: The rapid land subsidence in BJP has been alleviated since the South-to-North Water Diversion Project. …”
    Get full text
    Article
  11. 4351
  12. 4352
  13. 4353
  14. 4354

    Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus by Deming Tang, Asaiti Bukai, Shuai Qin, Ran Duan, Dongyue Lyu, Zhaokai He, Xiaojin Zheng, Weiwei Wu, Junrong Liang, Haifu Qu, Aidai Bieke, Peng Zhang, Dan Zhang, Haonan Han, Qun Duan, Huaiqi Jing, Xin Wang

    Published 2025-02-01
    “…In this study, we investigated the F1 antibody against Yersinia pestis in the sera of mother-neonate shepherd dog pairs in the Marmota himalayana plague focus of the Altun-Qilian Mountains, Qinghai-Tibetan Plateau, China. Seropositive shepherd dogs lived in plague-endemic regions, where marmots were infected with Y. pestis, whereas seronegative dogs lived in non-endemic regions. …”
    Get full text
    Article
  15. 4355
  16. 4356
  17. 4357
  18. 4358
  19. 4359
  20. 4360

    Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes by Guanyue Su, Silin Li, Donghua Zhang, Yongjian Zhou, Ling Wang, Yiqiang Yuan, Guowu Qian, Guotao Li, Na Han, Ming Cheng, Guangming Li, Shixi Zhang, Hong Luo, Mengzhao Yang, Yanyang Zhang, Zhan Song, Jiyuan Xing, Zujiang Yu, Zhigang Ren

    Published 2025-02-01
    “…Summary: Azvudine and nirmatrelvir-ritonavir are prioritized treatments for SARS-CoV-2 infection in China, but their effectiveness and safety in hospitalized patients with COVID-19 and pre-existing diabetes remains unknown. …”
    Get full text
    Article